Multiple cellular pathways controlling apoptosis and cell cycle

Multiple cellular pathways controlling apoptosis and cell cycle refers to a broad set of interconnected biological processes that govern programmed cell death and the stages of cell division (Source: NIH, National Cancer Institute). These pathways are essential for maintaining cellular homeostasis and ensuring that damaged or unnecessary cells are eliminated while healthy cells proliferate appropriately (Source: Nature Reviews Molecular Cell Biology). Key components include the BCL-2 family of proteins, which regulate mitochondrial outer membrane permeabilization, and cyclin-dependent kinases (CDKs), which drive the cell cycle forward (Source: PubMed, PMID: 25766284). In many diseases, particularly cancer, these pathways are frequently mutated or dysregulated, allowing cells to bypass growth-arrest signals and survive under stressful conditions (Source: Cell, Hanahan and Weinberg, 2011). Therapeutic intervention often involves targeting specific nodes within these pathways, such as using BH3 mimetics like Venetoclax to induce apoptosis or CDK inhibitors like Palbociclib to halt the cell cycle (Source: FDA, Drugs@FDA). Because this term encompasses a wide array of distinct molecular targets rather than a single receptor or enzyme, it is classified as a functional category rather than a specific therapeutic target.

Other names

Apoptosis and cell cycle regulatory pathwaysCell death and proliferation signaling cascadesProgrammed cell death and cell division control

Inhibition of anti-apoptotic proteins (e.g., BCL-2) to trigger programmed cell death or inhibition of cyclin-dependent kinases (e.g., CDK4/6) to arrest the cell cycle in the G1 phase.